Person

Paul Goldenheim

Former medical director of Purdue.

3 links, 3 backed by primary records

Legal records

Misbranding of OxyContin

2007 Convicted by U.S. District Court, Western District of Virginia: a misdemeanor count of misbranding OxyContin as a responsible corporate officer (a strict-liability offense) 1 2

Connections 3

The Purdue Frederick Company Executive vice president of worldwide medical affairs (former, at the 2007 plea) Primary record 1

U.S. District Court, Western District of Virginia 2007 a misdemeanor count of misbranding OxyContin as a responsible corporate officer (a strict-liability offense) Primary record 1 2

Purdue Frederick guilty pleas (2007) pleaded guilty to a misdemeanor Primary record 1

Timeline 1 date

Proof 2 sources

The Purdue Frederick Company, Inc. and Top Executives Plead Guilty to Misbranding OxyContin; Will Pay Over $600 Million, U.S. Attorney’s Office, Western District of Virginia, 10 May 2007. Primary record Archived copy
President and Chief Operating Officer Michael Friedman, Executive Vice President and Chief Legal Officer Howard Udell, and former Executive Vice President of Worldwide Medical Affairs Paul D. Goldenheim, pleaded guilty to a misdemeanor charge of misbranding OxyContin.
former Executive Vice President of Worldwide Medical Affairs Paul D. Goldenheim
Statement of John L. Brownlee before the Senate Judiciary Committee: Ensuring That Death and Serious Injury Are More Than a Business Cost: OxyContin and Defective Products, U.S. Senate Committee on the Judiciary, 31 Jul 2007. Primary record Archived copy
The statute which formed the basis for the guilty pleas requires no proof of intent or actual knowledge of the violations by the corporate officials to establish their guilt for the misdemeanor offense.

Page history 1 change